Kedar S Vaidya

发表

Large deflection model for nonlinear flexural vibration analysis of a highly flexible rotor-bearing system

Barun Pratiher, Hanmant P Phadatare, Vinay Maheshwari, 2017 .

Inhibition of CXCR4 by CTCE-9908 inhibits breast cancer metastasis to lung and bone.

Kedar S Vaidya, D. Wong, D. Welch, 2009, Oncology reports.

Breast cancer metastasis suppressor 1 up-regulates miR-146, which suppresses breast cancer metastasis.

Kedar S Vaidya, C. Benz, G. Scott, 2009, Cancer research.

Breast cancer metastasis suppressor 1 coordinately regulates metastasis‐associated microRNA expression

Dongquan Chen, Kedar S Vaidya, D. Welch, 2009, International journal of cancer.

Metastasis suppressors genes in cancer.

Kedar S Vaidya, D. Welch, Danny R Welch, 2008, The international journal of biochemistry & cell biology.

Requirement of KISS1 secretion for multiple organ metastasis suppression and maintenance of tumor dormancy.

Kedar S Vaidya, J. Kappes, M. Accavitti-Loper, 2007, Journal of the National Cancer Institute.

Over-expression of the BRMS1 family member SUDS3 does not suppress metastasis of human cancer cells.

Kedar S Vaidya, D. Ayer, D. Welch, 2009, Cancer letters.

Expression of the Breast Cancer Metastasis Suppressor 1 (BRMS1) maintains in vitro chemosensitivity of breast cancer cells.

Kedar S Vaidya, E. Kim, D. Welch, 2009, Cancer letters.

Gli1 enhances migration and invasion via up-regulation of MMP-11 and promotes metastasis in ERα negative breast cancer cell lines

Kedar S Vaidya, D. Welch, D. Hurst, 2011, Clinical & Experimental Metastasis.

Metastasis Research Society-American Association For Cancer Research Joint Conference on Metastasis.

Kedar S Vaidya, D. Welch, A. Mastro, 2008, Cancer research.

BRMS1 suppresses breast cancer experimental metastasis to multiple organs by inhibiting several steps of the metastatic process.

Kedar S Vaidya, D. Welch, D. Hurst, 2008, The American journal of pathology.

Calcitonin increases invasiveness of prostate cancer cells: Role for cyclic AMP‐dependent protein kinase A in calcitonin action

Kedar S Vaidya, K. Iczkowski, D. Reardon, 2005, International journal of cancer.

Exploiting selective BCL-2 family inhibitors to dissect cell survival dependencies and define improved strategies for cancer therapy

Dolores Diaz, Jun Chen, Deepak Sampath, 2015, Science Translational Medicine.

ABBV-399, a c-Met Antibody–Drug Conjugate that Targets Both MET–Amplified and c-Met–Overexpressing Tumors, Irrespective of MET Pathway Dependence

Kedar S Vaidya, L. Naumovski, Mark G. Anderson, 2016, Clinical Cancer Research.

Anti-c-Met monoclonal antibody ABT-700 breaks oncogene addiction in tumors with MET amplification

Kedar S Vaidya, L. Naumovski, P. Ansell, 2016, BMC Cancer.

Targeting Multiple EGFR-expressing Tumors with a Highly Potent Tumor-selective Antibody–Drug Conjugate

Kedar S Vaidya, A. Scott, Mark G. Anderson, 2020, Molecular Cancer Therapeutics.

Characterization of ABBV-221, a Tumor-Selective EGFR-Targeting Antibody Drug Conjugate

Kedar S Vaidya, A. Scott, A. Phillips, 2018, Molecular Cancer Therapeutics.

ABT-414, an Antibody–Drug Conjugate Targeting a Tumor-Selective EGFR Epitope

Kedar S Vaidya, A. Phillips, Dong Cheng, 2016, Molecular Cancer Therapeutics.

Breast Cancer Metastasis Suppressor-1 Differentially Modulates Growth Factor Signaling*

Kedar S Vaidya, G. Casey, D. Welch, 2008, Journal of Biological Chemistry.

EXPERIMENTAL THERAPEUTICS AND PHARMACOLOGY

Tina N. Davis, Forrest M Kievit, Atique U. Ahmed, 2013 .

Metastasis Suppressors and Their Roles in Breast Carcinoma

Kedar S Vaidya, D. Welch, 2007, Journal of Mammary Gland Biology and Neoplasia.

Alterations of BRMS1-ARID4A Interaction Modify Gene Expression but Still Suppress Metastasis in Human Breast Cancer Cells*

Kedar S Vaidya, M. Accavitti-Loper, D. Welch, 2008, Journal of Biological Chemistry.

BRMS1 suppresses breast cancer metastasis in multiple experimental models of metastasis by reducing solitary cell survival and inhibiting growth initiation

Kedar S Vaidya, I. Macdonald, A. Chambers, 2008, Clinical & Experimental Metastasis.

Metastasis suppressor KISS1 seems to reverse the Warburg effect by enhancing mitochondrial biogenesis.

Kedar S Vaidya, T. Iwakuma, S. Ballinger, 2014, Cancer research.

A “Prozone-Like” Effect Influences the Efficacy of the Monoclonal Antibody ABT-700 against the Hepatocyte Growth Factor Receptor

Kedar S Vaidya, Mark G. Anderson, W. N. Pappano, 2017, Pharmacology.

The Volume of Three-Dimensional Cultures of Cancer Cells InVitro Influences Transcriptional Profile Differences and Similarities with Monolayer Cultures and Xenografted Tumors

Catarina Brito, Xin Lu, Kedar S Vaidya, 2017, Neoplasia.

Tumor and Stem Cell Biology MetastasisSuppressorKISS 1 Seems toReverse theWarburg Effect by Enhancing Mitochondrial Biogenesis

Kedar S Vaidya, T. Iwakuma, S. Ballinger, 2014 .

Abstract 1943: PARG inhibitors exhibit synthetic lethality with XRCC1 deficiency and a cellular mechanism of action that is distinct from PARP inhibition

Kedar S Vaidya, M. P. Dillon, M. Fischer, 2018, Experimental and Molecular Therapeutics.

Synergistic therapeutic benefit by combining the antibody drug conjugate, depatux-m with temozolomide in pre-clinical models of glioblastoma with overexpression of EGFR

Kedar S Vaidya, A. Phillips, P. Ansell, 2021, Journal of Neuro-Oncology.

Anti-c-Met monoclonal antibody ABT-700 breaks oncogene addiction in tumors with MET amplification

Kedar S Vaidya, L. Naumovski, P. Ansell, 2016, BMC Cancer.

Homotypic gap junctional communication associated with metastasis suppression increases with PKA activity and is unaffected by PI3K inhibition.

Kedar S Vaidya, D. Welch, A. Landar, 2010, Cancer research.

Subsets of ATP‐sensitive potassium channel (KATP) inhibitors increase gap junctional intercellular communication in metastatic cancer cell lines independent of SUR expression

Kedar S Vaidya, D. Welch, A. Landar, 2012, FEBS letters.

Breast Cancer Metastasis Suppressor-1 Differentially Modulates Growth Factor Signaling*

Kedar S Vaidya, G. Casey, D. Welch, 2008, Journal of Biological Chemistry.

ABT-414, an Antibody–Drug Conjugate Targeting a Tumor-Selective EGFR Epitope

Kedar S Vaidya, A. Phillips, Dong Cheng, 2016, Molecular Cancer Therapeutics.